Alexander Yakobson

569 total citations
48 papers, 378 citations indexed

About

Alexander Yakobson is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Alexander Yakobson has authored 48 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Alexander Yakobson's work include Cancer Immunotherapy and Biomarkers (22 papers), Lung Cancer Treatments and Mutations (12 papers) and CAR-T cell therapy research (7 papers). Alexander Yakobson is often cited by papers focused on Cancer Immunotherapy and Biomarkers (22 papers), Lung Cancer Treatments and Mutations (12 papers) and CAR-T cell therapy research (7 papers). Alexander Yakobson collaborates with scholars based in Israel and Czechia. Alexander Yakobson's co-authors include Walid Shalata, Keren Rouvinov, Abed Agbarya, Nir Peled, Omar Abu Saleh, Chun Ho Szeto, Waleed Kian, Amichay Meirovitz, Omar Saleh and Eldad Silberstein and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Alexander Yakobson

42 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alexander Yakobson Israel 12 252 107 58 51 48 48 378
Walid Shalata Israel 11 224 0.9× 141 1.3× 61 1.1× 48 0.9× 30 0.6× 62 388
Patrick S. Rush United States 6 244 1.0× 123 1.1× 110 1.9× 82 1.6× 16 0.3× 15 340
Yonghao Yang China 11 200 0.8× 93 0.9× 25 0.4× 41 0.8× 77 1.6× 39 292
Elise F. Nassif United States 9 159 0.6× 192 1.8× 51 0.9× 80 1.6× 25 0.5× 37 305
Pauline Laly France 8 350 1.4× 75 0.7× 13 0.2× 75 1.5× 51 1.1× 16 460
Kai Qing China 12 86 0.3× 174 1.6× 85 1.5× 70 1.4× 52 1.1× 35 351
Camilla Delli Paoli Italy 11 136 0.5× 114 1.1× 12 0.2× 49 1.0× 16 0.3× 22 288
J. Madelaine France 10 223 0.9× 208 1.9× 29 0.5× 41 0.8× 16 0.3× 33 406
Helen Clare Dearden United Kingdom 5 316 1.3× 90 0.8× 8 0.1× 58 1.1× 82 1.7× 13 368
Chunji Chen China 10 96 0.4× 114 1.1× 19 0.3× 188 3.7× 33 0.7× 31 361

Countries citing papers authored by Alexander Yakobson

Since Specialization
Citations

This map shows the geographic impact of Alexander Yakobson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Yakobson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Yakobson more than expected).

Fields of papers citing papers by Alexander Yakobson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Yakobson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Yakobson. The network helps show where Alexander Yakobson may publish in the future.

Co-authorship network of co-authors of Alexander Yakobson

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Yakobson. A scholar is included among the top collaborators of Alexander Yakobson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Yakobson. Alexander Yakobson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Agbarya, Abed, et al.. (2025). Real-World Data on Osimertinib-Associated Cardiac Toxicity. Journal of Clinical Medicine. 14(5). 1754–1754. 2 indexed citations
3.
Yakobson, Alexander, et al.. (2025). Exploring the Impact of TP53 Mutation and Wild-Type Status on the Efficacy of Immunotherapy in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 26(14). 6939–6939. 1 indexed citations
4.
Shalata, Walid, et al.. (2025). Correlation Between Body Mass Index and Immunotherapy Response in Advanced NSCLC. Cancers. 17(7). 1149–1149.
5.
Shalata, Walid, et al.. (2024). Perimyocarditis Associated with Immune Checkpoint Inhibitors: A Case Report and Review of the Literature. Medicina. 60(2). 224–224. 2 indexed citations
6.
Shalata, Walid, et al.. (2024). Colorectal Cancer in Elderly Patients: Insights into Presentations, Prognosis, and Patient Outcomes. Medicina. 60(12). 1951–1951. 1 indexed citations
7.
8.
Yakobson, Alexander, et al.. (2023). Carpal Tunnel Syndrome Associated with Immune Checkpoint Inhibitors. Journal of Personalized Medicine. 13(9). 1340–1340. 4 indexed citations
9.
Yakobson, Alexander, et al.. (2023). PD-1 Inhibitors in Elderly and Immunocompromised Patients with Advanced or Metastatic Cutaneous Squamous Cell Carcinoma. Cancers. 15(16). 4041–4041. 13 indexed citations
10.
Shalata, Walid, et al.. (2023). Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature Review. Medicina. 59(11). 1946–1946. 6 indexed citations
11.
Shalata, Walid, et al.. (2023). Safety and rapid response of dabrafenib and trametinib therapy during hyperbilirubinemia in metastatic melanoma. Frontiers in Oncology. 13. 1102330–1102330. 3 indexed citations
12.
Yakobson, Alexander, et al.. (2023). Bullous Pemphigoid Occurring after Stopping Imatinib Therapy of CML: Is a Continuation of Post-Treatment Follow-Up Needed?. SHILAP Revista de lepidopterología. 13(5). 1082–1089. 1 indexed citations
13.
14.
Shalata, Walid, et al.. (2023). Unexpected Adverse Events of Immune Checkpoint Inhibitors. Life. 13(8). 1657–1657. 8 indexed citations
15.
16.
Szeto, Chun Ho, Walid Shalata, Alexander Yakobson, & Abed Agbarya. (2021). Neoadjuvant and Adjuvant Immunotherapy in Early-Stage Non-Small-Cell Lung Cancer, Past, Present, and Future. Journal of Clinical Medicine. 10(23). 5614–5614. 29 indexed citations
17.
Yakobson, Alexander, et al.. (2020). Recent Changes and Innovations in Melanoma Treatment: A Review.. PubMed. 11(22). 704–710. 5 indexed citations
18.
Yakobson, Alexander, Laila C. Roisman, Sara Morgenstern, et al.. (2020). ROS1 in Squamous Non-Small Cell Lung Cancer—Combined Immunotherapy (PD1/CTLA4) or Targeted Therapy?. Journal of Cancer Therapy. 11(6). 365–370. 1 indexed citations
19.
Rouvinov, Keren, et al.. (2019). Nivolumab Induced Lethal Aplastic Anemia in a Patient with Metastatic Melanoma. Case Reports in Oncology. 12(1). 29–32. 8 indexed citations
20.
Rouvinov, Keren, Alexander Yakobson, Samuel Ariad, Endre Z. Neulander, & Wilmosh Mermershtain. (2015). Primitive Neuroectodermal Tumor of the Kidney: A Case Report. Clinical Genitourinary Cancer. 13(4). e333–e336. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walid Shalata Breakdown of academic impact, for papers by Patrick S. Rush Breakdown of academic impact, for papers by Yonghao Yang Breakdown of academic impact, for papers by Elise F. Nassif Breakdown of academic impact, for papers by Pauline Laly Breakdown of academic impact, for papers by Kai Qing Breakdown of academic impact, for papers by Camilla Delli Paoli Breakdown of academic impact, for papers by J. Madelaine Breakdown of academic impact, for papers by Helen Clare Dearden Breakdown of academic impact, for papers by Chunji Chen
Rankless by CCL
2026